719 results found.
OrthoPediatrics Posts 3Q17 YoY Growth of 22%
OrthoPediatrics posted 3Q17 revenue of US $12.4MM, +22.1% vs. 3Q16, and YTD revenue of $34.0MM, +22.2%
Mazor Robotics 3Q17 Revenue +126% vs. 3Q16
Mazor Robotics reported 3Q17 revenue of US $17.2MM, +126.3% from 3Q16, and YTD revenue of $44.4MM, +99.1% vs. the prior y...
K2M 3Q17 Revenue Growth Up 6% YoY
K2M posted 3Q17 revenue of US $62.7MM, +5.6% vs. 3Q16, and YTD revenue of $190.3MM, +8.8% vs. the prior year.
i-FACTOR Peptide Enhanced Bone Graft in Use at >150 U.S. Hospitals
Cerapedics' i-FACTOR™ Peptide Enhanced Bone Graft is now in use at >150 U.S. hospitals.
Bone Solutions CEO Offers Startups Product Launch Advice
Bone Solutions launched OsteoCrete magnesium oxide-based bone void filler in 3Q17. The product was cleared by FDA in 2009 and remains the only bone void filler on the U.S. market to use magnesium, according to company Chief Executive Officer Drew Diaz. 
Orthobiologics Activity Signals Collaborations and Clinical Data Essential for Company Growth
By Julie A. Vetalice ORTHOWORLD estimates that global orthobiologic product sales account for ~10% of the orthopaedic market’s revenue, overall. In 2016, that translated to just over $4.9 billion, an increase of 3% vs. 2015. For this year and into 2019, we’re projecting simi...
Mazor 3Q17 Order Update, Preliminary Revenue
Mazor Robotics announced preliminary 3Q17 revenue of US $17.2MM, an increase of more than 225% vs. 3Q16. 
Smith & Nephew CEO Announces Retirement; Acquisition Buzz Returns
Smith & Nephew's Chief Executive Officer, Olivier Bohuon, announced his intention to retire by the end of 2018 after seven years in the positio...
Spine Companies $100MM to $2BB: Strategic Activity Update
Update, September 2018: ORTHOWORLD has published a new Spine Company Sales document with final 2017 revenue estimates. Access it here. The ma...
Mazor Robotics Gains CE Mark Approval for Mazor X
Mazor Robotics received CE Mark approval for the Mazor X Surgical Assurance Platform. 
Highmark Now Covers Zyga SI Fusion System
U.S. insurer Highmark now covers all U.S. FDA-cleared instrumentation for SI joint fusion, including cages or screws, with or without b...
China: Do You Need to Revamp Your Customer Channel?
By: Helen Chen and Stephen Sunderland L.E.K. Consulting An effective and efficient pathway to customers is important everywhere in orthopaedics, but perhaps nowhere is it more critical and complex than in China.
Cerapedics 2-Year Follow-Up Data on i-FACTOR Bone Graft in the Cervical Spine
Follow-up data from an IDE clinical trial of Cerapedics' i-FACTOR™ bone graft indicated statistica...
Medtronic Launches Study of INFUSE in PLF and TLIF
Medtronic launched a long-term global clinical study to collect prospective data on INFUSE® bone graft in
Mazor Robotics and Medtronic Enter Next Phase of Strategic Partnership
Mazor Robotics entered Phase II of its strategic partnership with Medtronic, which will now take on exc...
Medtronic Posts FY1Q18 Revenue Growth
ORTHOWORLD estimates Medtronic’s FY1Q18 revenue at US $728.0MM, +1.0% vs. FY1Q17. (Quarter ended 7/28/17) 
NuVasive 2Q17 Revenue and Organizational Changes
NuVasive reported 2Q17 revenue of US $260.6MM, +10.3% vs. 2Q16, and 1H17 revenue of $510.4MM, +13.1% vs. 1H16....
Mazor Robotics 2Q17 Revenue Up 87% Year Over Year
Mazor Robotics reported 2Q17 revenue of US $15.5MM, +86.7% from 2Q16, and 1H17 revenue of $27.2MM, +85.0%
Top Orthopaedic Device Companies: Ranking #6 to #15
Update: 2017 revenue for the 20 largest orthopaedic device companies can be found in the latest installment of  THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®.
DePuy Synthes Company Profile
We're redesigning Company Profiles. To get the most current news and articles about DePuy Synthes in the interim,
Strategic Orthopaedic-related 510(k)s Issued in June 2017: Hip Recon and Spine Devices
Strategic orthopaedic-related 510(k)s issued in June 2017 include: Telix K Interbody System (Biedermann Motech); iTotal Hip Replacement (ConforMIS...
David Dvorak Departs as Zimmer Biomet CEO
Zimmer Biomet announced the departure of David Dvorak, its CEO of ten years. Dan Florin, Senior Vice President and CFO,...
Medtronic Recalls Kyphon Directional Bone Void Filler Device
Medtronic is recalling its KYPHON® Directional Bone Void Filler due to a misalignment issue that may cause injected...
1H17 Funding Recap: Investors Continue to Back Regulatory-Approved Orthopaedic Technologies
The 24 funding announcements we tracked by orthopaedic companies in 1H17 kept pace with the number of announcements made in the first halves of 2016 and 2015, signaling that the environment to raise capital remains consistent, but difficult. Risk-adverse private equity, venture capital and other ...
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group